SinoMab Signs 3-Year Biomedicine R&D Deal with Hong Kong Institute

MT Newswires Live

08/13

SinoMab BioScience (HKG:3681) has signed a three-year agreement with Sun Yat-sen University Institute of Advanced Studies, Hong Kong, to jointly conduct research and development in biomedicine, according to a Tuesday bourse filing.

Shares of the biopharmaceutical firm fell over 2% in Wednesday's midday trade.

The partnership covers joint research, shared use of Shenzhen-based laboratory facilities, technical support for regulatory engagement, and training programs, with links to the University of Oxford.

SinoMab will provide at least one drug candidate for clinical development in the US and China and fund SYSU-IAS HK$1 million per quarter to support the projects.

The deal aims to accelerate innovative drug development and promote the translation of scientific research into clinical applications.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2559679771"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2559679771\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2559679771?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-13 13:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2559679771","market":"sh","top_or_hot":-1,"title":"SinoMab Signs 3-Year Biomedicine R&D Deal with Hong Kong Institute","media":"MT Newswires Live","content":"<html><body><p> SinoMab BioScience (HKG:3681) has signed a three-year agreement with Sun Yat-sen University Institute of Advanced Studies, Hong Kong, to jointly conduct research and development in biomedicine, according to a Tuesday bourse filing.</p><p>Shares of the biopharmaceutical firm fell over 2% in Wednesday's midday trade.</p><p>The partnership covers joint research, shared use of Shenzhen-based laboratory facilities, technical support for regulatory engagement, and training programs, with links to the University of Oxford.</p><p>SinoMab will provide at least one drug candidate for clinical development in the US and China and fund SYSU-IAS HK$1 million per quarter to support the projects.</p><p>The deal aims to accelerate innovative drug development and promote the translation of scientific research into clinical applications.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SinoMab Signs 3-Year Biomedicine R&D Deal with Hong Kong Institute</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSinoMab Signs 3-Year Biomedicine R&D Deal with Hong Kong Institute\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-08-13 13:07</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> SinoMab BioScience (HKG:3681) has signed a three-year agreement with Sun Yat-sen University Institute of Advanced Studies, Hong Kong, to jointly conduct research and development in biomedicine, according to a Tuesday bourse filing.</p><p>Shares of the biopharmaceutical firm fell over 2% in Wednesday's midday trade.</p><p>The partnership covers joint research, shared use of Shenzhen-based laboratory facilities, technical support for regulatory engagement, and training programs, with links to the University of Oxford.</p><p>SinoMab will provide at least one drug candidate for clinical development in the US and China and fund SYSU-IAS HK$1 million per quarter to support the projects.</p><p>The deal aims to accelerate innovative drug development and promote the translation of scientific research into clinical applications.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03681","symbol_name":"中國抗體-B","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2559679771","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2559679771","pubTimestamp":1755061672,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"SinoMab BioScience  has signed a three-year agreement with Sun Yat-sen University Institute of Advanced Studies, Hong Kong, to jointly conduct research and development in biomedicine, according to a Tuesday bourse filing.Shares of the biopharmaceutical firm fell over 2% in Wednesday's midday trade.The partnership covers joint research, shared use of Shenzhen-based laboratory facilities, technical support for regulatory engagement, and training programs, with links to the University of Oxford.SinoMab will provide at least one drug candidate for clinical development in the US and China and fund SYSU-IAS HK$1 million per quarter to support the projects.The deal aims to accelerate innovative drug development and promote the translation of scientific research into clinical applications.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03681":"中国抗体-B","BK1161":"生物科技","BK1574":"生物医药B类股"},"translate_title":"SinoMab与香港研究所签署为期3年的生物医药研发协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03681":0.9},"content_text":"SinoMab BioScience (HKG:3681) has signed a three-year agreement with Sun Yat-sen University Institute of Advanced Studies, Hong Kong, to jointly conduct research and development in biomedicine, according to a Tuesday bourse filing.Shares of the biopharmaceutical firm fell over 2% in Wednesday's midday trade.The partnership covers joint research, shared use of Shenzhen-based laboratory facilities, technical support for regulatory engagement, and training programs, with links to the University of Oxford.SinoMab will provide at least one drug candidate for clinical development in the US and China and fund SYSU-IAS HK$1 million per quarter to support the projects.The deal aims to accelerate innovative drug development and promote the translation of scientific research into clinical applications.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}